Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Myriad Genetics
| Metric | Myriad Genetics MYGNOther |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $825M |
| Net income (latest) | −$366M |
| Operating margin | −47.0% |
| Net margin | −44.4% |
| Return on equity | −99.4% |
| Return on assets | −51.8% |
| Return on capital (ROCE) | −67.6% |
| Debt / equity | 0.92× |
| Revenue growth (YoY) | −1.6% |
| Altman Z″ (distress) | -5.88 |
| Accruals / assets | −52.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.